| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2001 | EP1087771A1 Use of a nk-1 receptor antagonist for treating bipolar disorders |
| 04/04/2001 | EP1087769A1 Use of a pyridazinone derative |
| 04/04/2001 | EP1087768A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 04/04/2001 | EP1087767A2 Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| 04/04/2001 | EP1087766A1 Method of treatment |
| 04/04/2001 | EP1087765A2 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| 04/04/2001 | EP1087764A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 04/04/2001 | EP1087763A1 Neurotrophic difluoroamide agents |
| 04/04/2001 | EP1087762A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 04/04/2001 | EP1087761A2 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| 04/04/2001 | EP1087760A1 Compositions and methods for treatment of cough |
| 04/04/2001 | EP1087757A1 Method for making tablets with active principle sustained-release |
| 04/04/2001 | EP1087752A2 Method for producing liposomal formulations of active agents |
| 04/04/2001 | EP1087750A1 Pharmaceutical formulations for aerosols with two or more active substances |
| 04/04/2001 | EP1087748A1 Method of making antiperspirant powders |
| 04/04/2001 | EP1087747A1 Foaming composition for hair care |
| 04/04/2001 | EP1087735A1 Adhesively applied external nasal strips and dilators containing medications and fragrances |
| 04/04/2001 | EP1087663A2 Caspases and apoptosis |
| 04/04/2001 | EP1087662A1 Composition for keeping away vermin |
| 04/04/2001 | EP1087661A1 Il-8 receptor antagonists |
| 04/04/2001 | EP0983291A4 Carbamate-derivatized nucleosides and oligonucleosides |
| 04/04/2001 | EP0954320A4 Inositol polyphosphate derivatives and methods of using same |
| 04/04/2001 | EP0954274A4 Topical product formulations containing strontium for reducing skin irritation |
| 04/04/2001 | EP0929216A4 Method of treating post menopausal diseases, including osteoporosis |
| 04/04/2001 | EP0828489A4 Smoking cessation treatments using naltrexone and related compounds |
| 04/04/2001 | EP0824515B1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them |
| 04/04/2001 | EP0808315B1 Carbapenem-3-carboxylic acid ester derivatives |
| 04/04/2001 | EP0788515B1 Non-antigenic branched polymer conjugates |
| 04/04/2001 | EP0738263B1 Substituted phenylimidazolidines having antiandrogen activity |
| 04/04/2001 | EP0710662B1 Quinolinecarboxylic acid derivative |
| 04/04/2001 | EP0650732B1 Novel medicinal composition |
| 04/04/2001 | EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 04/04/2001 | EP0630888B1 Imidazoline derivative, production thereof, and blood pressure retentive |
| 04/04/2001 | EP0620732B1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/04/2001 | EP0588796B1 Sampangine derivatives useful as antifungal and antimycobacterial agents |
| 04/04/2001 | CN1290303A Use of negative regulation elements for nerve-specific expression of transgenes |
| 04/04/2001 | CN1290269A 5'-deoxycytidine derivatives |
| 04/04/2001 | CN1290268A Nucleosides |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290265A Thrombin receptor antagonists |
| 04/04/2001 | CN1290264A Triazine angiogenesis inhibitors |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/04/2001 | CN1290255A Dihydroxyhexanoic acid derivatives |
| 04/04/2001 | CN1290253A Heterocyclic topoisomerase poisons |
| 04/04/2001 | CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/04/2001 | CN1290247A Process and intermediates useful to make antifolates |
| 04/04/2001 | CN1290177A Crystallographically stable amorphous sephalosporin compositions and process for producing the same |
| 04/04/2001 | CN1290172A Topical composition containing human epidermal growth factor |
| 04/04/2001 | CN1290171A Composition and method for regulating cell proliferation and cell death |
| 04/04/2001 | CN1290170A Peritoneal dialysis solution containing modified icodextrins |
| 04/04/2001 | CN1290169A Preventives and remedies for ischemic reflow disorder |
| 04/04/2001 | CN1290168A Inhibition of membrane-associated viral replication |
| 04/04/2001 | CN1290167A Dried or frozen pharmaceutical prepartion containing class III antiarrhythmic compound |
| 04/04/2001 | CN1290166A Treatment of Dyskinesie |
| 04/04/2001 | CN1290165A Benzothiazole Protein tyrosine kinase inhibitors |
| 04/04/2001 | CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas |
| 04/04/2001 | CN1290163A Pharmaceuticals comprising N,N'-BIS(2-Hydroxybenzy) ethylenediamine-N, N'-diacetic acid for iron chelating therapy |
| 04/04/2001 | CN1290162A Taurine derivatives usable in treatment of ophthamic disorders |
| 04/04/2001 | CN1290161A Nuclear receptor ligands and ligand binding domains |
| 04/04/2001 | CN1290160A Pharmaceutical composition comprising combination of metformin and fibrate, and its use for treatment of hyperglycemia |
| 04/04/2001 | CN1289778A Synthesis of ketonic acid lactone amino carbomate antibiotics |
| 04/04/2001 | CN1289766A Penicillene compounds and derivatives therefrom |
| 04/04/2001 | CN1289595A Injection for treating clavus |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/04/2001 | CN1289593A Application of oligose mixture in treating stress brain injury |
| 04/04/2001 | CN1289592A Application of oligose treating stress brain injury |
| 04/04/2001 | CN1289591A Medicinal method for exuviating scorpion |
| 04/04/2001 | CN1289590A Protecting agent for preventing infection of schistosomiasis |
| 04/04/2001 | CN1064048C Five compounds of Qingyang ginseng glucoside and its preparation method and application |
| 04/04/2001 | CN1064045C Thienopyrimidine derivatives, their production and use |
| 04/04/2001 | CN1064044C Heterocyclic compounds, their production and use |
| 04/04/2001 | CN1064042C Intermediate of benzazepine derivative |
| 04/04/2001 | CN1064041C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them |
| 04/04/2001 | CN1063958C Formula for uraemia medicine |
| 04/04/2001 | CN1063957C Method for preparing fagopyrum cymosum preparation |
| 04/04/2001 | CN1063956C Liniment tongibing for cold-type arthralgia |
| 04/04/2001 | CN1063944C Method for preparing compound tobramycin suspension for eye |
| 04/04/2001 | CN1063943C Pharmaceutical compositions containing aminoglycosidic antibiotic, suitable for the topical administration |
| 04/04/2001 | CN1063942C Use of thiazolidine derivative for making medicaments |
| 04/03/2001 | US6211425 Patch |
| 04/03/2001 | US6211393 Radicals linked to si are si--o--c, si--s--c or si--n--c type bonds and are hydrolyzable in vivo, forming si--oh bonds that are biologically active especially when in contact with living tissue |
| 04/03/2001 | US6211386 Hydrogenating precursor compound, the e-geometrical isomer thereof or a mixture of the z- and e-isomers in the presence of catalyst containing rh, a chiral ligand with at least one phosphorous atom |
| 04/03/2001 | US6211376 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 04/03/2001 | US6211375 Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient |
| 04/03/2001 | US6211373 Phenyl urea antagonists of the IL-8 receptor |
| 04/03/2001 | US6211372 Pharmaceutical compositions and methods for use |
| 04/03/2001 | US6211368 Hydrolysis of corresponding ester |
| 04/03/2001 | US6211367 Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity |
| 04/03/2001 | US6211366 Psychological, nervous system disorders |
| 04/03/2001 | US6211364 Process for preparing indane-like compounds |
| 04/03/2001 | US6211362 Pyrroloazepine compounds |
| 04/03/2001 | US6211361 Oxidation, reduction of hymenin |
| 04/03/2001 | US6211360 Drug abruse therapy; plant extracts |
| 04/03/2001 | US6211349 Protonated/acidified nucleic acids and methods of use |
| 04/03/2001 | US6211348 As antibiotics |
| 04/03/2001 | US6211334 Cell-cycle regulatory proteins, and uses related thereto |
| 04/03/2001 | US6211273 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 04/03/2001 | US6211249 Polyester polyether block copolymers |
| 04/03/2001 | US6211247 Administration of resveratrol to prevent or treat restenosis following coronary intervention |